ClearSign Technologies Corp (CLIR) - Dilution Analysis

8-K filing: ClearSign Technologies Corporation entered into an underwriting agreement for a firm-commitment public offering of 777,780 shares of common stock at $4.33 per share. ($3.37M proceeds)

10-Q filing | 5.6M shares outstanding

10-K filing | 5.6M shares outstanding

8-K filing: Stock split 1-for-10 | Outstanding: 55,744,062 → 5,574,406

10-Q filing | 55.7M shares outstanding

10-Q filing | 55.2M shares outstanding

S-1 filing: This prospectus relates to the issuance of up to 5,267,222 shares of our common stock available for issuance upon the exercise of 5,267,222 redeemable warrants previously issued as part of our public offering of shares of common stock and accompanying Warrants, that was completed on April 23, 2024.

S-3 filing: This is an S-3 filing for a potential offering of up to $50,000,000 in debt securities, common stock, preferred stock, warrants, subscription rights and units, with a separate ATM offering of common stock up to $10,390,000.

10-Q filing | 55.0M shares outstanding

10-K filing | 0.0M shares outstanding

10-Q filing | 38.7M shares outstanding

10-Q filing | 38.7M shares outstanding

S-1/A filing: This prospectus relates to the resale, from time to time, by the selling stockholders identified in this prospectus under the section heading "Selling Stockholders," of up to (a) 5,599,763 shares of our common stock (the "Private Shares"), (b) up to 4,498,642 shares of common stock (the "Pre-Funded Warrant Shares") issuable upon the exercise of pre-funded warrants (the "Pre-Funded Warrants"), (c) 15,147,606 shares of common stock (the "Private Warrant Shares," and together with the Pre-Funded Warrant Shares, the "Warrant Shares") issuable upon the exercise of redeemable warrants (the "Private Warrants," and together with the Pre-Funded Warrants, the "Warrants"), and (d) 15,147,606 Private Warrants issued in connection with both the Private Placement and exercise of the Participation Right.

8-K filing: ClearSign Technologies Corporation issued 3,350,000 shares of common stock, pre-funded warrants to purchase up to 1,343,000 shares of common stock, and private warrants to purchase up to 7,039,500 shares of common stock to clirSPV LLC for aggregate gross proceeds of approximately $4.3 million. ($12.9M proceeds)

8-K filing: SPV exercised its participation right to purchase 3,907,000 shares of common stock, pre-funded warrants to purchase up to 786,000 shares of common stock and redeemable warrants to purchase up to 7,039,500 shares of common stock in connection with the company's recently consummated underwritten public offering and concurrent private placement.

S-1 filing: This S-1 filing registers the resale of common stock issuable upon exercise of pre-funded warrants and private warrants, along with shares of common stock offered by the selling stockholder.

10-Q filing | 38.8M shares outstanding

8-K filing: ClearSign Technologies Corporation's underwriter exercised its over-allotment option to purchase 693,114 shares of common stock and accompanying common warrants at $0.92 per set, expected to close around May 15, 2024, and the company agreed to issue warrants to the underwriter to purchase 55,449 shares of common stock. ($0.64M proceeds)

8-K filing: The Company closed its underwritten public offering and concurrent private placement, issuing shares of common stock and warrants, resulting in gross proceeds of approximately $9.3 million.

8-K filing: ClearSign Technologies Corporation entered into an amendment to a securities purchase agreement for a private placement involving the issuance of common stock, pre-funded warrants, and redeemable warrants, expected to close on April 23, 2024. ($5.0M proceeds)

8-K filing: ClearSign Technologies Corporation executed an underwritten public offering of 4,620,760 shares of common stock and redeemable warrants to purchase 4,620,760 shares, along with a concurrent private offering of 5,405,405 shares of common stock and redeemable warrants to purchase 8,108,108 shares, both expected to close on April 23, 2024. ($9.25M proceeds)

10-K filing | 38.5M shares outstanding

10-Q filing | 38.6M shares outstanding

10-Q filing | 38.5M shares outstanding

S-3 filing: This prospectus relates to the offer and sale from time to time by the selling stockholder named in this prospectus of up to 2,246,019 shares of common stock, par value $0.0001 per share, of ClearSign Technologies Corporation.

10-Q filing | 38.3M shares outstanding

10-K filing | 35.3M shares outstanding

10-Q filing | 37.9M shares outstanding

10-Q filing | 33.5M shares outstanding

S-3/A filing: The filing is an S-3/A amendment to register the offering of debt securities, common stock, preferred stock, warrants, units, or subscription rights up to $50,000,000 and provides an update on an At-the-Market Sales Agreement.

S-3 filing: This S-3 filing indicates the company may offer and sell up to $50,000,000 in various securities, including debt, common stock, preferred stock, warrants, units, or subscription rights, and they have an at-the-market sales agreement with Virtu Americas LLC to sell common stock up to $8.8 million.

8-K filing: ClearSign Technologies Corporation closed its underwritten public offering of 4,186,000 shares of common stock at a price of $1.11 per share on June 1, 2022. ($4.65M proceeds)

8-K filing: ClearSign Technologies Corporation completed a public offering of 3,640,000 shares of common stock at $1.11 per share, with the underwriter exercising an over-allotment option for an additional 546,000 shares, expecting net proceeds of approximately $4.2 million.

10-Q filing | 31.8M shares outstanding

10-K filing | 31.6M shares outstanding

10-Q filing | 31.5M shares outstanding

10-Q filing | 31.5M shares outstanding

10-Q filing | 31.3M shares outstanding

10-K filing | 30.9M shares outstanding

10-Q filing | 30.0M shares outstanding

8-K filing: ClearSign Technologies Corporation entered into an underwriting agreement with National Securities Corporation for the issuance and sale of 2,250,000 shares of common stock at $2.00 per share, with the underwriter exercising its option to purchase an additional 337,500 shares to cover over-allotments.

10-Q filing | 26.7M shares outstanding

10-Q filing | 26.7M shares outstanding

10-K filing | 26.7M shares outstanding